Key Decisions Approved by Board
- Dr. Rajamannar Thennati (DIN: 001415412) retires from the Board of Directors upon completion of his term at the ensuing 21st Annual General Meeting on August 10, 2026.
- Appointment of Mr. Anil Raghavan (DIN: 03548731), currently Chief Executive Officer of the Company, as Managing Director and Chief Executive Officer with effect from August 11, 2026. The appointment is liable to retire by rotation and subject to shareholder approval at the 21st Annual General Meeting.
Additional Director Information
Mr. Anil Raghavan is not related to any other director of the Company and is not debarred from holding the office of director by any SEBI order or any other authority.
Regulatory Compliance Details
The disclosure includes Annexure A containing details required under Regulation 30 read with Para A of Schedule III (Part A) of SEBI Listing Regulations, along with additional details required pursuant to SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Annexure A Details
| Particulars | Mr. Anil Raghavan | Dr. Rajamannar Thennati |
| Reason for change | Appointment | Retirement |
| Date of appointment/cessation | August 11, 2026 | August 10, 2026 |
| Brief profile | Mr. Anil Raghavan currently serves as Chief Executive Officer of SPARC. He is responsible for developing and executing strategies to realize SPARC's vision of becoming a Global Pharmaceutical Leader with a portfolio of innovative solutions. He operates from SPARC's Mumbai office. Mr. Anil also serves as a mentor of an early stage Machine Learning company, AIRAMATRIX Private Limited which focuses on the application of high content image processing and deep learning to transform drug development and clinical practice. Anil spent a decade consulting with leading firms such as Arthur Andersen, KPMG and Cambridge. | Not Applicable |
Document Metadata
- AGM Reference: 21st Annual General Meeting scheduled for August 10, 2026